Lista de obras -

A Single Dose of Unadjuvanted Novel 2009 H1N1 Vaccine Is Immunogenic and Well Tolerated in Young and Elderly Adults ⬇️

artículo científico publicado el 1 de noviembre de 2010

A bovine parainfluenza virus type 3 vaccine is safe and immunogenic in early infancy

artículo científico publicado en 2005

A gene deletion that up-regulates viral gene expression yields an attenuated RSV vaccine with improved antibody responses in children.

artículo científico publicado en 2015

A global pandemic influenza vaccine action plan

artículo científico publicado en 2006

A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults.

artículo científico publicado en 2009

A live attenuated H9N2 influenza vaccine is well tolerated and immunogenic in healthy adults.

artículo científico publicado en 2009

A live attenuated influenza A(H5N1) vaccine induces long-term immunity in the absence of a primary antibody response.

artículo científico publicado en 2014

A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in young infants

artículo científico publicado en 2003

A prospective study of agents associated with acute respiratory infection among young American Indian children

artículo científico publicado en 2013

A role for immune complexes in enhanced respiratory syncytial virus disease

artículo científico publicado en 2002

An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults

artículo científico publicado en 2011

An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults

artículo científico publicado en 2012

Anti-G protein antibody responses to respiratory syncytial virus infection or vaccination are associated with inhibition of G protein CX3C-CX3CR1 binding and leukocyte chemotaxis

artículo científico publicado en 2004

Association of C-Reactive Protein With Bacterial and Respiratory Syncytial Virus-Associated Pneumonia Among Children Aged <5 Years in the PERCH Study

scholarly article by Melissa M Higdon et al published 15 June 2017 in Clinical Infectious Diseases

Attenuation of Live Respiratory Syncytial Virus Vaccines Is Associated With Reductions in Levels of Nasal Cytokines ⬇️

artículo científico publicado el 12 de marzo de 2013

Boosted Influenza-Specific T Cell Responses after H5N1 Pandemic Live Attenuated Influenza Virus Vaccination.

artículo científico publicado en 2015

Breathing new life into pneumonia diagnostics

artículo científico publicado en 2009

C5 modulates airway hyperreactivity and pulmonary eosinophilia during enhanced respiratory syncytial virus disease by decreasing C3a receptor expression

artículo científico publicado en 2006

Challenges and opportunities in RSV vaccine development: Meeting report from FDA/NIH workshop

artículo científico publicado en 2016

Chest Radiograph Findings in Childhood Pneumonia Cases From the Multisite PERCH Study

scholarly article by Nicholas Fancourt et al published 15 June 2017 in Clinical Infectious Diseases

Clinical Predictors of Critical Lower Respiratory Tract Illness Due to Respiratory Syncytial Virus in Infants and Children: Data to Inform Case Definitions for Efficacy Trials

artículo científico publicado en 2016

Clinical evaluation of a single oral dose of human-bovine (UK) reassortant rotavirus vaccines Wa x UK (P1A[8],G6) and Wa x (DS-1 x UK) (P1A[8],G2)

scientific article published on 01 March 2002

Colonization Density of the Upper Respiratory Tract as a Predictor of Pneumonia-Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus, and Pneumocystis jirovecii

scholarly article by Daniel Park et al published 15 June 2017 in Clinical Infectious Diseases

Comparison of results of detection of rhinovirus by PCR and viral culture in human nasal wash specimens from subjects with and without clinical symptoms of respiratory illness

artículo científico publicado en 2007

Comparison of temple temperatures with rectal temperatures in children under two years of age.

artículo científico publicado en 2002

Data and product needs for influenza immunization programs in low- and middle-income countries: Rationale and main conclusions of the WHO preferred product characteristics for next-generation influenza vaccines

artículo científico publicado en 2017

Density of Upper Respiratory Colonization With Streptococcus pneumoniae and Its Role in the Diagnosis of Pneumococcal Pneumonia Among Children Aged <5 Years in the PERCH Study

scholarly article by Henry C Baggett et al published 15 June 2017 in Clinical Infectious Diseases

Detection of Pneumococcal DNA in Blood by Polymerase Chain Reaction for Diagnosing Pneumococcal Pneumonia in Young Children From Low- and Middle-Income Countries

scholarly article by Susan C Morpeth et al published 15 June 2017 in Clinical Infectious Diseases

Determining the burden of respiratory syncytial virus disease: the known and the unknown

artículo científico publicado en 2017

Determining the outcomes of interventions to prevent respiratory syncytial virus disease in children: what to measure?

artículo científico publicado en 2017

Differential production of inflammatory cytokines in primary infection with human metapneumovirus and with other common respiratory viruses of infancy

artículo científico publicado en 2004

Digital auscultation in PERCH: Associations with chest radiography and pneumonia mortality in children

scientific article published on 27 August 2020

Disk diffusion bioassays for the detection of antibiotic activity in body fluids: applications for the Pneumonia Etiology Research for Child Health project

artículo científico

Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial

artículo científico publicado en 2015

Evaluation of Pneumococcal Load in Blood by Polymerase Chain Reaction for the Diagnosis of Pneumococcal Pneumonia in Young Children in the PERCH Study

scholarly article by Maria Deloria Knoll et al published 15 June 2017 in Clinical Infectious Diseases

Evaluation of Pneumonia Virus of Mice as a Possible Human Pathogen ⬇️

artículo científico publicado el 21 de marzo de 2012

Evaluation of a Live Attenuated Human Metapneumovirus Vaccine in Adults and Children

artículo científico publicado en 2017

Evaluation of a Live-Attenuated Human Parainfluenza Type 1 Vaccine in Adults and Children

artículo científico publicado en 2014

Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young children

artículo científico publicado en 2004

Evaluation of fast-track diagnostics and TaqMan array card real-time PCR assays for the detection of respiratory pathogens

artículo científico publicado en 2014

Evaluation of two chimeric bovine-human parainfluenza virus type 3 vaccines in infants and young children

artículo científico publicado en 2011

Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults.

artículo científico publicado en 2009

Experimental infection of adults with recombinant wild-type human metapneumovirus

artículo científico publicado en 2013

Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants

artículo científico publicado en 2005

Identifying Gaps in Respiratory Syncytial Virus Disease Epidemiology in the United States Prior to the Introduction of Vaccines

artículo científico publicado en 2017

Immune Response Following H1N1pdm09 Vaccination: Differences in Antibody Repertoire and Avidity in Young Adults and Elderly Populations Stratified by Age and Gender ⬇️

artículo científico publicado el 29 de diciembre de 2011

Impact of Placental Malaria and Hypergammaglobulinemia on Transplacental Transfer of Respiratory Syncytial Virus Antibody in Papua New Guinea

artículo científico publicado en 2015

Informing randomized clinical trials of respiratory syncytial virus vaccination during pregnancy to prevent recurrent childhood wheezing: A sample size analysis

scholarly article by Corinne A Riddell et al published 22 November 2018 in Vaccine

Is Higher Viral Load in the Upper Respiratory Tract Associated With Severe Pneumonia? Findings From the PERCH Study

scholarly article by Daniel Feikin et al published 15 June 2017 in Clinical Infectious Diseases

Laboratory Methods for Determining Pneumonia Etiology in Children ⬇️

artículo científico publicado el 1 de abril de 2012

Limited Utility of Polymerase Chain Reaction in Induced Sputum Specimens for Determining the Causes of Childhood Pneumonia in Resource-Poor Settings: Findings From the Pneumonia Etiology Research for Child Health (PERCH) Study

article

Live Respiratory Syncytial Virus (RSV) Vaccine Candidate Containing Stabilized Temperature-Sensitivity Mutations Is Highly Attenuated in RSV-Seronegative Infants and Children

artículo científico publicado en 2018

Live Respiratory Syncytial Virus Attenuated by M2-2 Deletion and Stabilized Temperature Sensitivity Mutation 1030s Is a Promising Vaccine Candidate in Children

artículo científico publicado en 2020

Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate With Deletion of RNA Synthesis Regulatory Protein M2-2 is Highly Immunogenic in Children

artículo científico publicado en 2018

Live-attenuated respiratory syncytial virus vaccine with M2-2 deletion and with SH non-coding region is highly immunogenic in children

artículo científico publicado en 2020

Live-attenuated respiratory syncytial virus vaccines

artículo científico publicado en 2013

Meeting report: WHO consultation on Respiratory Syncytial Virus (RSV) vaccine development, Geneva, 25-26 April 2016.

artículo científico publicado en 2017

Microscopic Analysis and Quality Assessment of Induced Sputum From Children With Pneumonia in the PERCH Study

scholarly article by David Murdoch et al published 15 June 2017 in Clinical Infectious Diseases

Mortality due to Respiratory Syncytial Virus. Burden and Risk Factors

artículo científico publicado en 2016

Motavizumab, RSV, and subsequent wheezing – Authors' reply

artículo científico publicado en 2016

Multiplex assay for detection of strain-specific antibodies against the two variable regions of the G protein of respiratory syncytial virus

artículo científico publicado en 2002

Pertussis-Associated Pneumonia in Infants and Children From Low- and Middle-Income Countries Participating in the PERCH Study

scientific article published on December 2016

Phase 2 evaluation of parainfluenza type 3 cold passage mutant 45 live attenuated vaccine in healthy children 6-18 months old.

artículo científico publicado en 2004

Pneumonia etiology research for child health. Introduction

artículo científico publicado en 2012

Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response

artículo científico publicado en 2021

Prevention and Control of Influenza With Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015-16 Influenza Season

artículo científico publicado en 2015

Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015-16 Influenza Season

artículo científico publicado en 2015

Prevention and Control of Seasonal Influenza with Vaccines

artículo científico publicado en 2016

Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) -- United States, 2014-15 influenza season

artículo científico publicado en 2014

Progress in the development of human parainfluenza virus vaccines ⬇️

artículo científico publicado el 1 de agosto de 2011

Progress in the development of respiratory syncytial virus and parainfluenza virus vaccines

artículo científico publicado en 2003

Public health and biosecurity. The obligation to prevent the next dual-use controversy

artículo científico publicado en 2012

Report of the WHO technical consultation on the effect of maternal influenza and influenza vaccination on the developing fetus: Montreal, Canada, September 30-October 1, 2015.

artículo científico publicado en 2017

Respiratory syncytial virus infection in Navajo and White Mountain Apache children

artículo científico publicado en 2002

Respiratory syncytial virus vaccine research and development: World Health Organization technological roadmap and preferred product characteristics

artículo científico publicado en 2018

Risk factors for severe respiratory syncytial virus infection among Alaska native children

artículo científico publicado en 2002

Safety and Immunogenicity of the Respiratory Syncytial Virus Vaccine RSV/ΔNS2/Δ1313/I1314L in RSV-Seronegative Children

scientific article published on 12 October 2019

Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young children

artículo científico publicado en 2013

Should Controls With Respiratory Symptoms Be Excluded From Case-Control Studies of Pneumonia Etiology? Reflections From the PERCH Study

article

Social justice and disadvantaged groups.

artículo científico publicado en 2007

Specimen collection for the diagnosis of pediatric pneumonia

artículo científico publicado en 2012

Standardization of Clinical Assessment and Sample Collection Across All PERCH Study Sites

artículo científico publicado en 2017

Standardization of Laboratory Methods for the PERCH Study

artículo científico publicado en 2017

The Advisory Committee on Immunization Practices recommendation regarding the use of live influenza vaccine: A rejoinder

artículo científico publicado en 2017

The Diagnostic Utility of Induced Sputum Microscopy and Culture in Childhood Pneumonia

article

The Effect of Antibiotic Exposure and Specimen Volume on the Detection of Bacterial Pathogens in Children With Pneumonia

scholarly article by Amanda J Driscoll et al published 15 June 2017 in Clinical Infectious Diseases

The Impact of Respiratory Syncytial Virus Disease Prevention on Pediatric Asthma

artículo científico publicado en 2016

The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines

artículo científico publicado en 2007

The cDNA-derived Investigational Human Parainfluenza Virus Type 3 Vaccine rcp45 Is Well Tolerated, Infectious, and Immunogenic in Infants and Young Children ⬇️

artículo científico publicado el 1 de octubre de 2011

The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxin

artículo científico publicado en 2005

The future of respiratory syncytial virus vaccine development

artículo científico publicado en 2004

The impact of infection with human metapneumovirus and other respiratory viruses in young infants and children at high risk for severe pulmonary disease

artículo científico publicado en 2006

The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humans

artículo científico publicado en 2006

The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates

scholarly article by Natalie I Mazur et al published October 2018 in Lancet Infectious Diseases

The role of neutralizing antibodies in protection of American Indian infants against respiratory syncytial virus disease

artículo científico publicado en 2008

Transmissibility, infectivity and immunogenicity of a live human parainfluenza type 3 virus vaccine (HPIV3cp45) among susceptible infants and toddlers

artículo científico publicado en 2005

Tribute to Caren Hall

artículo científico publicado en 2013

Use and evaluation of molecular diagnostics for pneumonia etiology studies

artículo científico publicado en 2012

Vaccination against respiratory syncytial virus in pregnancy

artículo científico publicado en 2016

Young infants can develop protective levels of neutralizing antibody after infection with respiratory syncytial virus

artículo científico publicado en 2008

rDEN4delta30, a live attenuated dengue virus type 4 vaccine candidate, is safe, immunogenic, and highly infectious in healthy adult volunteers

artículo científico publicado en 2005

Lista de obras de

A Single Dose of Unadjuvanted Novel 2009 H1N1 Vaccine Is Immunogenic and Well Tolerated in Young and Elderly Adults ⬇️

A bovine parainfluenza virus type 3 vaccine is safe and immunogenic in early infancy

A gene deletion that up-regulates viral gene expression yields an attenuated RSV vaccine with improved antibody responses in children.

A global pandemic influenza vaccine action plan

A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults.

A live attenuated H9N2 influenza vaccine is well tolerated and immunogenic in healthy adults.

A live attenuated influenza A(H5N1) vaccine induces long-term immunity in the absence of a primary antibody response.

A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in young infants

A prospective study of agents associated with acute respiratory infection among young American Indian children

A role for immune complexes in enhanced respiratory syncytial virus disease

An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults

An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults

Anti-G protein antibody responses to respiratory syncytial virus infection or vaccination are associated with inhibition of G protein CX3C-CX3CR1 binding and leukocyte chemotaxis

Association of C-Reactive Protein With Bacterial and Respiratory Syncytial Virus-Associated Pneumonia Among Children Aged <5 Years in the PERCH Study

Attenuation of Live Respiratory Syncytial Virus Vaccines Is Associated With Reductions in Levels of Nasal Cytokines ⬇️

Boosted Influenza-Specific T Cell Responses after H5N1 Pandemic Live Attenuated Influenza Virus Vaccination.

Breathing new life into pneumonia diagnostics

C5 modulates airway hyperreactivity and pulmonary eosinophilia during enhanced respiratory syncytial virus disease by decreasing C3a receptor expression

Challenges and opportunities in RSV vaccine development: Meeting report from FDA/NIH workshop

Chest Radiograph Findings in Childhood Pneumonia Cases From the Multisite PERCH Study

Clinical Predictors of Critical Lower Respiratory Tract Illness Due to Respiratory Syncytial Virus in Infants and Children: Data to Inform Case Definitions for Efficacy Trials

Clinical evaluation of a single oral dose of human-bovine (UK) reassortant rotavirus vaccines Wa x UK (P1A[8],G6) and Wa x (DS-1 x UK) (P1A[8],G2)

Colonization Density of the Upper Respiratory Tract as a Predictor of Pneumonia-Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus, and Pneumocystis jirovecii

Comparison of results of detection of rhinovirus by PCR and viral culture in human nasal wash specimens from subjects with and without clinical symptoms of respiratory illness

Comparison of temple temperatures with rectal temperatures in children under two years of age.

Data and product needs for influenza immunization programs in low- and middle-income countries: Rationale and main conclusions of the WHO preferred product characteristics for next-generation influenza vaccines

Density of Upper Respiratory Colonization With Streptococcus pneumoniae and Its Role in the Diagnosis of Pneumococcal Pneumonia Among Children Aged <5 Years in the PERCH Study

Detection of Pneumococcal DNA in Blood by Polymerase Chain Reaction for Diagnosing Pneumococcal Pneumonia in Young Children From Low- and Middle-Income Countries

Determining the burden of respiratory syncytial virus disease: the known and the unknown

Determining the outcomes of interventions to prevent respiratory syncytial virus disease in children: what to measure?

Differential production of inflammatory cytokines in primary infection with human metapneumovirus and with other common respiratory viruses of infancy

Digital auscultation in PERCH: Associations with chest radiography and pneumonia mortality in children

Disk diffusion bioassays for the detection of antibiotic activity in body fluids: applications for the Pneumonia Etiology Research for Child Health project

Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial

Evaluation of Pneumococcal Load in Blood by Polymerase Chain Reaction for the Diagnosis of Pneumococcal Pneumonia in Young Children in the PERCH Study

Evaluation of Pneumonia Virus of Mice as a Possible Human Pathogen ⬇️

Evaluation of a Live Attenuated Human Metapneumovirus Vaccine in Adults and Children

Evaluation of a Live-Attenuated Human Parainfluenza Type 1 Vaccine in Adults and Children

Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young children

Evaluation of fast-track diagnostics and TaqMan array card real-time PCR assays for the detection of respiratory pathogens

Evaluation of two chimeric bovine-human parainfluenza virus type 3 vaccines in infants and young children

Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults.

Experimental infection of adults with recombinant wild-type human metapneumovirus

Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants

Identifying Gaps in Respiratory Syncytial Virus Disease Epidemiology in the United States Prior to the Introduction of Vaccines

Immune Response Following H1N1pdm09 Vaccination: Differences in Antibody Repertoire and Avidity in Young Adults and Elderly Populations Stratified by Age and Gender ⬇️

Impact of Placental Malaria and Hypergammaglobulinemia on Transplacental Transfer of Respiratory Syncytial Virus Antibody in Papua New Guinea

Informing randomized clinical trials of respiratory syncytial virus vaccination during pregnancy to prevent recurrent childhood wheezing: A sample size analysis

Is Higher Viral Load in the Upper Respiratory Tract Associated With Severe Pneumonia? Findings From the PERCH Study

Laboratory Methods for Determining Pneumonia Etiology in Children ⬇️

Limited Utility of Polymerase Chain Reaction in Induced Sputum Specimens for Determining the Causes of Childhood Pneumonia in Resource-Poor Settings: Findings From the Pneumonia Etiology Research for Child Health (PERCH) Study

Live Respiratory Syncytial Virus (RSV) Vaccine Candidate Containing Stabilized Temperature-Sensitivity Mutations Is Highly Attenuated in RSV-Seronegative Infants and Children

Live Respiratory Syncytial Virus Attenuated by M2-2 Deletion and Stabilized Temperature Sensitivity Mutation 1030s Is a Promising Vaccine Candidate in Children

Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate With Deletion of RNA Synthesis Regulatory Protein M2-2 is Highly Immunogenic in Children

Live-attenuated respiratory syncytial virus vaccine with M2-2 deletion and with SH non-coding region is highly immunogenic in children

Live-attenuated respiratory syncytial virus vaccines

Meeting report: WHO consultation on Respiratory Syncytial Virus (RSV) vaccine development, Geneva, 25-26 April 2016.

Microscopic Analysis and Quality Assessment of Induced Sputum From Children With Pneumonia in the PERCH Study

Mortality due to Respiratory Syncytial Virus. Burden and Risk Factors

Motavizumab, RSV, and subsequent wheezing – Authors' reply

Multiplex assay for detection of strain-specific antibodies against the two variable regions of the G protein of respiratory syncytial virus

Pertussis-Associated Pneumonia in Infants and Children From Low- and Middle-Income Countries Participating in the PERCH Study

Phase 2 evaluation of parainfluenza type 3 cold passage mutant 45 live attenuated vaccine in healthy children 6-18 months old.

Pneumonia etiology research for child health. Introduction

Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response

Prevention and Control of Influenza With Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015-16 Influenza Season

Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015-16 Influenza Season

Prevention and Control of Seasonal Influenza with Vaccines

Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) -- United States, 2014-15 influenza season

Progress in the development of human parainfluenza virus vaccines ⬇️

Progress in the development of respiratory syncytial virus and parainfluenza virus vaccines

Public health and biosecurity. The obligation to prevent the next dual-use controversy

Report of the WHO technical consultation on the effect of maternal influenza and influenza vaccination on the developing fetus: Montreal, Canada, September 30-October 1, 2015.

Respiratory syncytial virus infection in Navajo and White Mountain Apache children

Respiratory syncytial virus vaccine research and development: World Health Organization technological roadmap and preferred product characteristics

Risk factors for severe respiratory syncytial virus infection among Alaska native children

Safety and Immunogenicity of the Respiratory Syncytial Virus Vaccine RSV/ΔNS2/Δ1313/I1314L in RSV-Seronegative Children

Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young children

Should Controls With Respiratory Symptoms Be Excluded From Case-Control Studies of Pneumonia Etiology? Reflections From the PERCH Study